|
Age, years, median (range)
|
35(5–52)
|
35(8–50)
|
0.679
|
|
Males/females, n
|
22/13
|
24/23
|
0.287
|
|
WBC count at diagnose × 109, median (range)
|
45.0(1.4–199.2)
|
36.3 (1.6–274.4)
|
0.147
|
|
CNS involvement
| | | |
|
Yes/no
|
3/32
|
6/41
|
0.548
|
|
Disease status at transplantation
| | | |
|
CR1
|
26
|
37
|
0.584
|
|
>CR1
|
9
|
10
| |
|
BCR-ABL at transplantation
| | | |
|
Negative/positive
|
28/7
|
37/10
|
0.888
|
|
Average mos. from diagnosis to transplant (range)
|
9.0(3–47)
|
7.0(2–19)
|
0.104
|
|
Cycles of prior chemotherapy (range)
|
5.3(2–22)
|
4.6(2–13)
|
0.411
|
|
ABO match, no. (%)
| | |
0.224
|
|
Matched
|
12
|
27
| |
|
Minor mismatched
|
8
|
7
| |
|
Major mismatched
|
11
|
9
| |
|
Major and minor mismatched
|
4
|
4
| |
|
Donor-recipient sex match
| | |
0.323
|
|
Male-male
|
10
|
16
| |
|
Male-female
|
9
|
18
| |
|
Female-male
|
12
|
8
| |
|
Female-female
|
4
|
5
| |
